Analytical Validation of the Karius Microbial Cell-Free DNA Sequencing Test for Infectious Disease | Karius
  • Filters
  • only
  • only
  • only
  • only
  • only
  • only
  • only
  • only
  • only

Select All / Deselect All

Reset

Analytical Validation of the Karius Microbial Cell-Free DNA Sequencing Test for Infectious Disease

In this webinar, Karius Co-Founder and Chief Scientific Officer Tim Blauwkamp presents results from the analytical validation of the Karius microbial cell-free DNA (cfDNA) sequencing test for pathogen detection.

 

 

Summary: Karius has developed and validated a comprehensive, next-generation sequencing test that identifies and quantifies microbial cfDNA in plasma from 1,320 clinically relevant pathogens, including bacteria, DNA viruses, fungi, and eukaryotic parasites. Particular attention will be paid to the novel strategies and experiments that were employed to characterize test performance across a broad range of pathogens throughout the analytical validation studies.

Webinar Topics:
- Introduction to the Karius Test
- Challenges to analytical validation of clinical metagenomics tests
- Karius analytical validation strategies and results
- Q & A